Anonymousabout 2 hours ago
Demis Hassabis's Isomorphic Labs has unveiled IsoDDE, an AI drug design engine that doubles AlphaFold 3's accuracy, and expects its first AI-designed drugs to enter clinical trials by late 2026. But with no AI-discovered drug yet approved by regulators, and Phase II success rates still matching the dismal industry average, the technology's ability to compress timelines and cut costs remains an unproven proposition — one that 2026's Phase III results may finally resolve.